91ÑÇÉ«´«Ã½

Award

Wang’s studies are fueled by interest in cells

He has won the 2022 91ÑÇÉ«´«Ã½ Young Investigator Award
Shravanti  Suresh
Dec. 16, 2021

is fascinated by the molecular biology of cells and the many levels of modifications they encompass to regulate gene expression.

“Follow your heart and do what interests you the most,” he said.

Greg Wang

Wang followed his heart from China, where he earned undergraduate and master’s degrees, to the University of California, San Diego, where he pursued basic research to understand how the cell works. During his Ph.D. in biomedical sciences, he showed that nuclear receptor binding SET domain 1, a family histone methylase transferase protein, is directly linked to transcriptional regulation of the Hox-A locus and histone modification dysregulation leading to cancer formation.

Now a professor at the University of North Carolina at Chapel Hill, Wang studies a number of chromatin-modulating enzyme machineries and histone reader proteins that have been shown to be critical for chromatin/gene regulation and often altered in disease states. He also studies phase separation of transcription factors, which is critically involved in pathogenesis. For these works, he has been named the winner of the 2022 91ÑÇÉ«´«Ã½’s 91ÑÇÉ«´«Ã½ Young Investigator Award.

“Whenever you pick a question to work on, the more fundamental and broader the question is, the more you will learn in the process of answering it,” Wang advises early-career scientists. The energy and curiosity of his students and postdocs fuel his fascination for chromatin biology, he said, and those lab members are leading his foray into molecular medicine.

The 91ÑÇÉ«´«Ã½ award adds to a growing list of accolades including the Yang Family Biomedical Scholar award and the Phillip and Ruth Hettleman Prize, both from UNC in 2019; the Leukemia & Lymphoma Society Scholar award in 2018; and the American Cancer Society Research Scholar award in 2016.

Three projects with a chromatin focus

At the 91ÑÇÉ«´«Ã½ annual meeting, Greg Wang will talk about his quest to answer questions in the field of chromatin biology and chromatin’s effect on gene (de)regulation and cancer formation.

Post-translational modification of histones leads to changes in the chromatin, which lead to fine-tuning of DNA-templated pathways. The misregulation of histone modifications can lead to oncogenesis due to misperception in cell identity and deregulation of gene-expression profiles. Wang was among the first to show that the deregulation of certain histone reader proteins is causal for initiating cancer.

The Wang lab also uses small-molecule inhibitors to target enzymes that modify histones. Along with collaborators, they have developed a set of epigenetic inhibitors via proteolysis targeting chimera, known as PROTAC, which can inhibit and degrade target oncoproteins in tumor cells.

Wang is also interested in how cancer cells use phase separation by acquiring mutations. This allows the cancer cells to enhance a genomic targeting of oncogenic transcription factors and to form a distorted chromatin 3D structure during tumorous transformation.

At the annual meeting, Wang will talk about his research integrating these major projects: cellular crosstalk involving chromatin regulation, phase separation that results in 3D chromatin organization and the development of small molecules to target oncoproteins in tumor cells.

Enjoy reading 91ÑÇÉ«´«Ã½ Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Shravanti  Suresh

Shravanti Suresh is a Ph.D. candidate in Dipali Sashital’s lab at Iowa State University and a volunteer 91ÑÇÉ«´«Ã½ Today contributor.

Get the latest from 91ÑÇÉ«´«Ã½ Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Hidden strengths of an autistic scientist
Essay

Hidden strengths of an autistic scientist

April 3, 2025

Navigating the world of scientific research as an autistic scientist comes with unique challenges —microaggressions, communication hurdles and the constant pressure to conform to social norms, postbaccalaureate student Taylor Stolberg writes.

Richard Silverman to speak at 91ÑÇÉ«´«Ã½ 2025
91ÑÇÉ«´«Ã½ Annual Meeting

Richard Silverman to speak at 91ÑÇÉ«´«Ã½ 2025

March 27, 2025

Richard Silverman and Melissa Moore are the featured speakers at the 91ÑÇÉ«´«Ã½ annual meeting to be held April 12-15 in Chicago.

Women’s History Month: Educating and inspiring generations
Observance

Women’s History Month: Educating and inspiring generations

March 27, 2025

Through early classroom experiences, undergraduate education and advanced research training, women leaders are shaping a more inclusive and supportive scientific community.

91ÑÇÉ«´«Ã½ honors Lawrence Tabak with public service award
Award

91ÑÇÉ«´«Ã½ honors Lawrence Tabak with public service award

March 26, 2025

He will deliver prerecorded remarks at the 2025 91ÑÇÉ«´«Ã½ Annual Meeting in Chicago.

91ÑÇÉ«´«Ã½ names 2025 JBC/Tabor Award winners
Award

91ÑÇÉ«´«Ã½ names 2025 JBC/Tabor Award winners

March 24, 2025

The six awardees are first authors of outstanding papers published in 2024 in the Journal of Biological Chemistry.

Daniel N. Hebert (1962–2024)
Retrospective

Daniel N. Hebert (1962–2024)

March 17, 2025

Daniel Hebert’s colleagues remember the passionate glycobiologistscientist, caring mentor and kind friend.